The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare ...

The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...

U.S. President Joe Biden on Tuesday proposed expanding coverage of anti-obesity drugs, like Novo Nordisk's Wegovy, for more ...

Officials want people to understand just how narrow their window to sign up for flexible gap-filler coverage is.

If confirmed to run the Centers for Medicare & Medicaid Services, television personality Dr. Mehmet Oz, President-elect ...

My wife and I looked into Medicare Advantage plans and discovered it wouldn't make sense for us -- be careful before ...

President-elect Trump’s choice of celebrity doctor and failed Senate candidate Mehmet Oz to run the Centers for Medicare and ...

More than seven million additional Americans could get coverage for popular drugs such as Zepbound and Wegovy under the ...

The proposal would slash out-of-pocket costs by as much as 95% for the drugs that can carry a price tag of $1,000 a month, ...

The proposal would let patients get Wegovy, Ozempic and related drugs for obesity, which Medicare and Medicaid does not cover ...